Skip to main content
editorial
. 2019 May 14;9(1):1616994. doi: 10.1080/20010001.2019.1616994

Figure 2.

Figure 2.

Multiple brain regions of the aging mouse can be targeted with Aβ42 and P301Ltau. This allows induction of pathology at a disease-relevant age and restricts pathology to injected brain regions based on their relevance to AD.